ArticleEuropean journal of nuclear medicine and molecular imaging2022

Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms.

Francesca Borgna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.